Arcturus Therapeutics Holdings Inc. Logo

Arcturus Therapeutics Holdings Inc.

A commercial-stage mRNA medicines company focused on rare and infectious diseases.

ARCT | US

Overview

Corporate Details

ISIN(s):
US03969T1097
LEI:
Country:
United States of America
Address:
10628 SCIENCE CENTER DRIVE, 92121 SAN DIEGO

Description

Arcturus Therapeutics Holdings Inc. is a commercial-stage messenger RNA (mRNA) medicines company focused on the discovery, development, and commercialization of therapeutics and vaccines. The company's primary areas of interest are infectious diseases and rare diseases, with a particular emphasis on respiratory and liver conditions. Its development pipeline includes candidates for Ornithine Transcarbamylase (OTC) deficiency (ARCT-810) and Cystic Fibrosis (ARCT-032), as well as vaccine programs. Arcturus leverages its proprietary technologies, including the LUNAR® lipid-mediated nanoparticle delivery system and the STARR® self-amplifying mRNA platform, to advance its portfolio of RNA-based medicines.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Arcturus Therapeutics Holdings Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arcturus Therapeutics Holdings Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arcturus Therapeutics Holdings Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biosergen AB Logo
Develops drugs to treat severe and resistant invasive fungal infections.
Sweden
BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies, human tissue models, and bio-laboratory products.
South Korea
086820
Biosynex Logo
Designs and distributes medical diagnostic solutions, including rapid tests and devices.
France
ALBIO
BIO-TECHNE Corp Logo
Global supplier of reagents and instruments for research and clinical diagnostic markets.
United States of America
TECH
Bioten Co., Ltd Logo
Develops and manufactures natural health foods, cosmetics, and animal feed additives.
South Korea
289170
Biotest AG Logo
Develops and supplies plasma protein products and biotherapeutic drugs from human plasma.
Germany
BIO3
Biotika A.S. Logo
A biotechnology company that manufactures APIs for human and veterinary applications.
Slovakia
BSL
Bioton S.A. Logo
A global manufacturer of recombinant human insulin and diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops and supplies sheep monoclonal antibodies for clinical diagnostic platforms.
United Kingdom
BVXP
Bioversys N Logo
Clinical-stage biopharma developing antibacterial therapies for antimicrobial resistance.
Switzerland
BIOV

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.